Company intelligence / Profile preview

VAR2 Pharmaceuticals

Copenhagen, Hovedstaden, Denmark
Ownership
Private
Development stage
Phase 1
01

Overview

Preclinical studies show that Vartumabs selectively target tumors with high specificity and minimal off-target effects. ADC formulations have demonstrated curative effects in various mouse models without significant toxicity. The first-in-human Phase 0 imaging study is underway to assess biodistribution and pharmacokinetics in patients with solid tumors. Initial patient enrollment was completed December 2024. Results from this study will inform future efficacy trials.

Therapeutic areas
Oncology
Modalities
Antibody-drug conjugates (ADCs)Bispecific antibodies (CD3-bispecifics)Single-chain variable fragments (scFvs)
Industry
Biotech
02

Drug pipeline

14 assets

vartumab

1

13 more assets in the full pipeline.

Request access →
03

Partnerships

AGC Biologics – manufacturing partner for antibody production and scale-up for clinical studiesTRACER CRO – partner for nuclear imaging clinical trial execution in the NetherlandsMilliporeSigma/Merck KGaA Advance Biotech Grant Program winner

Beyond the preview

Go deeper on VAR2 Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on VAR2 Pharmaceuticals.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call